Explore our Physico-chemical Characterization techniques in characterizing biopharmaceuticals for drug development, including proteins, antibodies, vaccines, and nucleic acid-based drugs using High Resolution Mass Spectrometry (HRMS).
Discover how Veeda Biopharma leverages its state-of-the-art infrastructure to accelerate development programs across diverse biopharmaceutical solutions such as Analytics & Characterization, Bioprocess Development, Discovery Biology, and Clinical Bioanalysis.
Explore the full range of late-phase clinical trial capabilities, from phase II to phase IV, in the fields of Oncology, Immunology, Respiratory, Hematology, Central nervous system(CNS) and Infectious diseases, delivering...
Discover our Phase I Trial Capabilities, specializing in first-in-human studies, early-phase clinical trials, and vaccine studies, pioneering the exploration of new medical interventions and paving the way for future advancements...
Discover our comprehensive Oncology Clinical Trial Capabilities, dedicated to advancing the field of cancer research through cutting-edge studies focused on Breast Cancer, Prostate Cancer, Ovarian Cancer, Multiple Myeloma, and Small...
Experience a transformative approach to Infectious Disease Drug-development Solutions, driving the discovery of innovative treatments to combat complex infectious diseases and promoting global well-being.
Veeda Group – Integrated Drug-development Services
Veeda provides a comprehensive range of services covering pre-clinical studies, Phase I to Phase IV clinical trials, bioavailability and bioequivalence studies, as well as bioanalytical services for both small and...
Endocrinology Drug Development Support: From Insulin to GLP-1 Receptors
State-of-the-Art Infrastructure & in-depth expertise supporting you at every stage of drug development and preparing for the next wave of Off-Patent Molecules.
Simplifying complex trials through smart design & strategic insights, bridging Eastern & Western markets by providing access to diverse patient populations and delivering substantial cost efficiencies.
Fluticasone Furoate: Accelerating Progress for Asthma & Allergy Treatments
Overcoming recruitment hurdles in asthma studies and developing validated bioanalytical methods to drive regulatory success and launch effective Asthma Therapies
Expertise in conducting transdermal patch studies for bioequivalence (BE) with pharmacokinetic (PK) endpoints and adhesion studies, along with skin irritation & sensitization studies
Accelerating Biologics Development with Scientific solutions. Specialised biological assay solutions to support peptides, monoclonal antibodies (mAb) and insulin-based biopharmaceutical development
Driving Vaccine Breakthroughs: Full-Scale Support at every step providing integrated early development, preclinical, clinical, and bioanalytical support tailored for each stage.
Customized Clinical Bioanalysis Solutions: Pharmacokinetics, Pharmacodynamics, immunogenicity testing, vaccine sciences and biomarker assays for the development of biotherapeutics with Good Clinical Laboratory Practice (GCLP) compliance.
Solution partner for physico-chemical, structural characterization and analytical CMC support for broad range of biotherapeutics ranging from peptides, oligos, recombinant-conjugated-fusion protein, monoclonal antibodies (mAbs), bispecific, antibody (Ab) fragments, antibody-drug conjugates to biopolymers.
